Search Results - "Hussain, S Farzana"
-
1
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
Published in Cancer research (Chicago, Ill.) (15-10-2007)“…Overcoming the profound immunosuppression in patients with solid cancers has impeded efficacious immunotherapy. Signal transducers and activators of…”
Get full text
Journal Article -
2
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy
Published in Cancer Immunology, Immunotherapy (01-01-2008)“…Despite the immunogenicity of glioblastoma multiforme (GBM), immune-mediated eradication of these tumors remains deficient. Regulatory T cells (Tregs) in the…”
Get full text
Journal Article -
3
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia
Published in PloS one (17-06-2009)“…Glioblastoma are rapidly proliferating brain tumors in which hypoxia is readily recognizable, as indicated by focal or extensive necrosis and vascular…”
Get full text
Journal Article -
4
Innate immune functions of microglia isolated from human glioma patients
Published in Journal of translational medicine (30-03-2006)“…Innate immunity is considered the first line of host defense and microglia presumably play a critical role in mediating potent innate immune responses to…”
Get full text
Journal Article -
5
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2006)“…Little is known about the immune performance and interactions of CNS microglia/macrophages in glioma patients. We found that microglia/macrophages were the…”
Get full text
Journal Article -
6
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors
Published in Cancer Immunology, Immunotherapy (01-06-2005)“…As a vaccine vector, Listeria monocytogenes targets the innate immune system, resulting in a cytokine response that enhances antigen-presenting cell function…”
Get full text
Journal Article -
7
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study
Published in Neuro-oncology (Charlottesville, Va.) (01-02-2008)“…Cytotoxic chemotherapy that induces lymphopenia is predicted to ablate the benefits of active antitumor immunization. Temozolomide is an effective…”
Get full text
Journal Article -
8
Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice
Published in Molecular therapy (01-09-2011)“…Vaccines that aim to expand tumor-specific CD8+ T cells have yielded disappointing results in cancer patients although they showed efficacy in transplantable…”
Get full text
Journal Article -
9
CD4+CD25+ regulatory T cells that secrete TGFβ and IL-10 are preferentially induced by a vaccine vector
Published in Journal of immunotherapy (1997) (01-09-2004)Get full text
Journal Article -
10
Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer
Published in Cancer immunity (06-02-2007)“…We have created a transgenic mouse with tissue-specific expression of the human papilloma virus (HPV) 16 E6 and E7 oncoproteins in the thyroid as a model of…”
Get full text
Journal Article -
11
The Ability of Two Listeria monocytogenes Vaccines Targeting Human Papillomavirus-16 E7 to Induce an Antitumor Response Correlates with Myeloid Dendritic Cell Function
Published in The Journal of immunology (1950) (15-05-2004)“…Previous work from our laboratory has shown that Lm-LLO-E7 induces complete regression of approximately 75% of established TC-1 tumors, whereas Lm-E7 only…”
Get full text
Journal Article -
12
Immunotherapy for human glioma: innovative approaches and recent results
Published in Expert review of anticancer therapy (01-10-2005)“…The outcome for malignant glioma patients remains dismal despite treatment with surgical resection, radiation and chemotherapy. The goal of immunotherapy is to…”
Get full text
Journal Article -
13
Differential SLP-76 Expression and TCR-Mediated Signaling in Effector and Memory CD4 T Cells
Published in The Journal of immunology (1950) (15-02-2002)“…We present in this study novel findings on TCR-mediated signaling in naive, effector, and memory CD4 T cells that identify critical biochemical markers to…”
Get full text
Journal Article -
14
Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy
Published in Cancer Immunology, Immunotherapy (01-01-2008)Get full text
Journal Article -
15
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1
Published in Neuro-oncology (Charlottesville, Va.) (01-07-2006)“…Little is known about the immune performance and interactions of CNS microglia/macrophages in glioma patients. We found that microglia/macrophages were the…”
Get full text
Journal Article -
16
Heterogeneity of the Memory CD4 T Cell Response: Persisting Effectors and Resting Memory T Cells
Published in The Journal of immunology (1950) (15-01-2001)“…Defining the cellular composition of the memory T cell pool has been complicated by an inability to distinguish effector and memory T cells. We present here an…”
Get full text
Journal Article -
17
CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector
Published in Journal of immunotherapy (1997) (01-09-2004)“…CD4CD25 T cells generated in a vaccine scenario can play a critical role in limiting antitumor therapy, thus having widespread implications for the…”
Get full text
Journal Article -
18
Effector CD4 T Cells Are Biochemically Distinct from the Memory Subset: Evidence for Long-Term Persistence of Effectors In Vivo
Published in The Journal of immunology (1950) (15-09-1999)“…Memory T cell responses are believed to be mediated by long-lived memory T cells that arise directly from a subset of short-lived, activated effector T cells…”
Get full text
Journal Article